| IMMX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the IMMX shares outstanding history going back to 11/15/2022:
Also see: IMMX Market Cap History IMMX YTD Return |
IMMX Shares Outstanding History — Immix Biopharma Share Count Over Time
As of 3/20/2026 Immix Biopharma has 52.96 million IMMX shares outstanding. Investors often track the IMMX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IMMX share count trends over time, with 15 historical shares outstanding datapoints presented, dating back to 11/15/2022.
| IMMX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||
IMMX Historical Shares Outstanding: +49.13% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| IMMX Stock Price Chart |
| About Immix Biopharma Inc |
| Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and autoimmune disease. Co.'s lead cell therapy asset is CAR-T NXC-201 for autoimmune disease, relapsed/refractory AL Amyloidosis, and relapsed/refractory multiple myeloma, which is being evaluated in its ongoing Phase Ib/IIa NEXICART-1 (NCT04720313) clinical trial. Its tissue specific therapeutic IMX-110 is in clinical trials as a monotherapy, and in combination with tislelizumab (BeiGene anti-PD-1 - IMMINENT-01 NCT05840835) for advanced solid tumors, such as relapsed/refractory colorectal cancer (CRC). We show 15 historical shares outstanding datapoints in our coverage of IMMX's shares outstanding history. Understanding the changing numbers of IMMX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IMMX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IMMX by allowing them to research IMMX shares outstanding history as well as any other stock in our coverage universe. |
| IMMX Current Stock Quote |
Quotes delayed 20 minutes  Free IMMX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| IMMX Share Performance |
| Shares Outstanding Peers |
| Immix Biopharma (IMMX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
IMMY Shares Outstanding History IMNM Shares Outstanding History IMNN Shares Outstanding History IMNP Shares Outstanding History IMPL Shares Outstanding History IMRA Shares Outstanding History IMRX Shares Outstanding History IMUX Shares Outstanding History IMV Shares Outstanding History IMVT Shares Outstanding History More Healthcare companies » |
IMMX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
